U.S. Markets open in 25 hrs, 14 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,220.96 | 32.73 | 0.29% |
| NASDAQ | 2,255.88 | -3.16 | -0.14% |
| S&P 500 | 1,242.31 | 5.48 | 0.44% |
| Day Low 09:30 AM EDT | 0.38 | |
|---|---|---|
| Day High 09:31 AM EDT | 0.41 |
|
| Range | 0.03 | |
| Volume | 76,633 | |
| 30-Day Avg. Vol. | 403,000 |
|
| Difference | -80.98% | |
| Market Cap. | 23.31 M | |
| Change | 582,880 | |
| Shares Out. | 58.28 M | |
| Percent Traded | 0.13% | |
| Revenue (LFY) | 24,000 | |
| Earnings (TTM) | -17.64 M | |
| Next Earnings | 11/3/08 |
|
| EPS (TTM) | -0.47 |
| 52-Wk Low 8/5/08 | 0.25 | |
|---|---|---|
| 52-Wk High 10/3/07 | 2.60 |
|
| Range | 2.35 | |
| Prev. Close 9/4/08 | 0.39 | |
| Today's Open | 0.38 | |
| Change | -2.56% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 2.1555 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
Titan Pharmaceuticals thinks big. The development-stage firm is working on drug treatments for large pharmaceutical markets, including central nervous system disorders like chronic pain, Parkinson's disease, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.11 3/31/08 | -0.10 3/31/08 |
0.01
Beat
|
| Last Quarter | -0.11 6/30/08 | -0.13 6/30/08 |
-0.02
Missed
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 12,000.00 | 24,000.00 |
| Gross Profit | -4.86 M | -12.22 M |
| Operating Income | -7.85 M | -18.43 M |
| Net Income | -7.68 M | -17.65 M |
